AstraZeneca rejects reports of Covid vaccine 'failures' among the elderly

AstraZeneca rejects reports of Covid vaccine 'failures' among the elderly

"Europe is determined to contribute to this global common good but it also means business", said von der Leyen.

"I'm confident that they [AstraZeneca and Pfizer] will both deliver for us the quantities that we need to meet our mid-February target and of course beyond that", Zahawi told Sky News.

He said "political concerns" related to some vaccines have arisen - particularly around manufacturing the AstraZeneca candidate.

The step has led to concern that the European Union might not allow shipments of the vaccine to non-European countries until their contracts are fulfilled.

Earlier this month, pharmaceutical giant Pfizer, which also developed a vaccine, said it would curb its own deliveries due to production delays at its Belgium plant.

The European Commission did not elaborate on the purported problem or what recourses exist in the contract, but a spokesman said: "The Commission expects contractual obligations to be met".

"At this point, we don't have sourcing of AstraZeneca coming from European manufacturers".

Canada has no ability now to produce COVID-19 vaccines but Prime Minister Justin Trudeau has insisted repeatedly that Canada will get enough vaccine doses for all Canadians who want it by the end of September.

That includes vaccines made by AstraZeneca and Johnson & Johnson.

AstraZeneca, which developed its shot with Oxford University, told the European Union on Friday it could not meet agreed supply targets up to the end of March, with an European Union official involved in the talks telling Reuters that meant a 60% cut to 31 million doses.

The bloc's executive branch, the European Commission, said Tuesday that it was preparing a scheme under which companies would have to register their vaccine exports from the EU.

"The European Union has supported the rapid development and production of several vaccines against COVID-19 with a total of 2.7 billion euros [$3.3 billion]".

Mr Soriot told Welt that the pharma company has a "best effort" agreement with the bloc to deliver a certain number of doses by a certain time, but was not contractually bound by it.

She said that it wasn't specifically in the remit of the EMA to boost production of a vaccine, but the agency would "do everything we can to facilitate production from a scientific and regulatory perspective".

He then signed an executive order in December demanding USA -produced vaccines be prioritized for Americans only and threatened to use the act to halt vaccine exports as well.

Health commissioner Stella Kyriakides conceded the firm had offered a "lack of clarity and insufficient explanations" on how to increase its supply to the Continent. Canada has no current ability to produce either those vaccines or the ones from Pfizer-BioNTech and Moderna.

Anita Anand, the Minister of Public Services and Procurement, expressed the same confidence on Tuesday. She said studies carried out so far were on a very small quantity of the elderly population.

"We don't know where this unsubstantiated report comes from, it's not true".

Trudeau is also expected to address calls for yet more travel restrictions as new strains are reported in Canada.